Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine - Wikidata - thesis-toulmin - TriplyDB

Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine

Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine

http://www.wikidata.org/entity/Q34059854

about

Vaccines, Adjuvants, and Dendritic Cell Activators--Current Status and Future Challenges.A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602)Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma.The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?Perioperative treatment with the new synthetic TLR-4 agonist GLA-SE reduces cancer metastasis without adverse effects.A viral vaccine encoding prostate-specific antigen induces antigen spreading to a common set of self-proteins in prostate cancer patients.Exploiting the critical perioperative period to improve long-term cancer outcomes Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression.Overview of cellular immunotherapy for patients with glioblastoma.Melanoma vaccines: mixed past, promising future.Cross-sectional and longitudinal analysis of cancer vaccination trials registered on the US Clinical Trials Database demonstrates paucity of immunological trial endpoints and decline in registration since 2008 Therapeutic cancer vaccines: are we there yet?Biomarkers as key contributors in treating malignant melanoma metastases.Development of Membrane-Bound GM-CSF and IL-18 as an Effective Tumor Vaccine.Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy.The early antitumor immune response is necessary for tumor growth: Re-visiting Prehn's hypothesis in the human melanoma system.Virotherapy, gene transfer and immunostimulatory monoclonal antibodies.Buccal injection of synthetic HPV long peptide vaccine induces local and systemic antigen-specific CD8+ T-cell immune responses and antitumor effects without adjuvant Multiple vaccinations: friend or foe.Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage-colony stimulating factor and interleukin-2 surface modified MB49 bladder cancer stem cells vaccine.Use of GM-CSF as an adjuvant with cancer vaccines: beneficial or detrimental?Cellular vaccine approaches Melanoma vaccines: developments over the past 10 years.Antigen-specific versus antigen-nonspecific immunotherapeutic approaches for human melanoma: the need for integration for optimal efficacy?Towards curative cancer immunotherapy: overcoming posttherapy tumor escape.Peptide-based vaccination and induction of CD8+ T-cell responses against tumor antigens in breast cancer.Adjuvant therapy for high-risk melanoma Development of a potent melanoma vaccine capable of stimulating CD8(+) T-cells independently of dendritic cells in a mouse model.Recent progress in GM-CSF-based cancer immunotherapy.Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696).Unique Th1/Th2 phenotypes induced during priming and memory phases by use of interleukin-12 (IL-12) or IL-28B vaccine adjuvants in rhesus macaques.Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer.

P2860

Q26796314-ED068F63-C093-47C4-B022-B5E88E92405A Q30411499-67F14022-9408-4ADC-BC9F-BBFBAF17E781 Q30412300-512D64B0-6291-4682-B6EA-824DD8BAF114 Q30425111-C5921642-A9EC-409C-9A04-A5F24AE65026 Q30700261-83FE2C04-E4BE-46EA-86B4-9B313ACDC150 Q33609458-3EE54CE1-2A17-4B25-B6FB-F1C49FD64A8F Q33871661-42A6A6C7-C089-44EF-8394-2387305CD831 Q33903025-5DC3BF5D-A5BC-494E-995F-798E71E62983 Q34189694-577CDADC-FB95-4A13-84C1-DD497982B61C Q34235476-73E915AA-E1E4-4E91-9563-6E268EACBCE2 Q34306503-127700B6-5D95-49E5-B794-C1BA7646D961 Q34786691-BECF6411-B720-4E44-903C-2A636034C4FE Q35550888-5F171307-4F36-4E34-AA83-F34644A7ADEA Q35695115-2CB8D972-1875-41A8-8A71-F16C596F792E Q35783465-98FC7DAD-C92E-43C8-B6F8-DC9B8C99DB7E Q35828574-C5DA7790-87D8-4247-A825-B55566465BC3 Q35928330-6CE61481-1E49-4181-87D3-EA7A697A126E Q36373379-6FD30F55-D7B7-4C62-9CD1-29C894800357 Q36456487-A9E1DA48-F576-4BEA-9CAE-DAB31FCCC04C Q36651899-5AE80466-68A3-458D-BA7C-C89A776BDD78 Q36734688-27F30ED7-AF16-47EF-88E4-CE0BF6E36D34 Q37693346-4E5CC97F-311C-4F6E-AFA9-2D95E6D42C84 Q37744997-65BBC705-1A97-47E1-8341-BCD4EB7F669D Q37778690-4DDB0B1D-AC6E-447F-B2E2-CAD196C068D2 Q37892595-770FC81B-858B-4CE2-A7C1-882B74FACD56 Q37952804-8520A950-5B1E-4CEF-BAF1-A8177080D554 Q38025094-EE17108D-36E3-4C02-9147-93738B5BE6CF Q38293525-9CF536EC-D25A-454C-BD3E-A4BBE6D94B55 Q38555842-5DB793DD-C897-4DD2-B8A3-37E48495ED00 Q38884592-63E30D91-792F-4A30-91D2-FF53AC074A4E Q39183386-09CB14A5-AE89-4DE8-8B79-B257E0ED5EF7 Q40841838-C72C8C6C-B74D-4A4C-84EC-4475ED846C9B Q42411131-BBAB672F-8CF4-43C2-A017-BEA3C658AECF Q42755227-28364EA2-CE4F-4DD0-BAAB-ABB647E64B1A

P2860

Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine

http://www.wikidata.org/entity/Q34059854

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Effect of granulocyte/macropha ...... ic whole-cell melanoma vaccine

@ast

Effect of granulocyte/macropha ...... ic whole-cell melanoma vaccine

@en

Effect of granulocyte/macropha ...... ic whole-cell melanoma vaccine

@nl

type

label

Effect of granulocyte/macropha ...... ic whole-cell melanoma vaccine

@ast

Effect of granulocyte/macropha ...... ic whole-cell melanoma vaccine

@en

Effect of granulocyte/macropha ...... ic whole-cell melanoma vaccine

@nl

prefLabel

Effect of granulocyte/macropha ...... ic whole-cell melanoma vaccine

@ast

Effect of granulocyte/macropha ...... ic whole-cell melanoma vaccine

@en

Effect of granulocyte/macropha ...... ic whole-cell melanoma vaccine

@nl

P1433

Q34059854-1E7336DA-1390-4E4A-9E41-DB9EF5682A23

P1476

Q34059854-B4CE02E2-A3C4-4D2A-B4D0-5CA58DD588C1

P2093

Q34059854-01309AE7-BDEE-4839-A3C2-0B96448579F8

Q34059854-3805B9FC-DB23-41A0-ADF6-325F5B087416

Q34059854-984B3531-98C5-4414-98E4-62DD1134FB60

Q34059854-9CA52F5E-2543-4F24-A2E3-AB2164B5B301

Q34059854-FF4DD456-F3AA-4635-A6A3-24436BC997C4

P2860

Q34059854-000DB1DB-A400-4BB6-8BB5-AD0A3EF68DCA

Q34059854-0B3108A8-AE3B-4C28-B769-0185889E3956

Q34059854-0CEC1771-1CF8-443C-B24A-F7E78377197D

Q34059854-0F133FE9-88E1-4488-94AB-C3806E750423

Q34059854-0FCBB09C-6568-4AAF-8618-76BD59F4358C

Q34059854-218266D3-E9C9-4919-9166-1631A2CBF581

Q34059854-229455AB-9C8B-4B6D-9831-BDD0A03A5D20

Q34059854-2893FEF0-D7E4-481D-9ED5-F873D82911A0

Q34059854-2DAF4023-5D96-45D9-B3E8-89F96703437B

Q34059854-3942F6B0-6E0D-4E19-8154-0A1B38CF8ECC

P304

Q34059854-8FF61D81-F1BF-49CA-B301-8C422979CE19

P31

Q34059854-D0E88618-5398-494A-BFC1-834D0A14AEB1

P356

Q34059854-8A9525C8-C2C9-4EDC-BAE0-A922271E6DEC

P407

Q34059854-A3B60B21-AF6B-4909-84F2-467F68682BB6

P433

Q34059854-0E90EE71-E2EF-48E5-A86C-C60937A5F9E4

P478

Q34059854-B8757B8D-5386-4F15-94E5-84262BADECCC

P50

Q34059854-64F05A46-03E4-42D1-8443-EAC44B370513

P577

Q34059854-9BB74CDF-4BFC-4D0C-A207-DAC436B794C0

P5875

Q34059854-30607E8D-1A59-430C-981D-30272F096842

P698

Q34059854-24DC3B3C-D257-4365-BB2F-E64400566555

P921

Q34059854-6D24B07A-1E85-4737-A929-414187EE0186

P932

Q34059854-31B94FCC-AECB-4B4B-A1F8-AB06EA0C5C19

P356

1078-0432.CCR-09-1540

P1433

Clinical Cancer Research

P1476

Effect of granulocyte/macropha ...... ic whole-cell melanoma vaccine

@en

P2093

Donald L Morton

http://www.w3.org/2001/XMLSchema#string

Eddy C Hsueh

http://www.w3.org/2001/XMLSchema#string

Mark B Faries

http://www.w3.org/2001/XMLSchema#string

Mary Hoban

http://www.w3.org/2001/XMLSchema#string

Xing Ye

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular physiology of granulocyte-macrophage colony-stimulating factor.

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion.

Derangement of immune responses by myeloid suppressor cells.

Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex.

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Role of immature myeloid cells in mechanisms of immune evasion in cancer.

Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients.

Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma: evidence of systemic immune dysfunction.

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells.

P304

7029-7035

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-09-1540

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38080504

http://www.w3.org/2001/XMLSchema#string

P698

19903777

http://www.w3.org/2001/XMLSchema#string

P921

P932

2920049

http://www.w3.org/2001/XMLSchema#string